Aarti Pharmalabs Ltd.

Aarti Pharmalabs has informed that it enclosed a Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024 received from Link Intime India, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.